Thyrocare To Divest Nueclear Healthcare Stake For ₹141.4 crore, Acquire Properties For ₹20.58 Crore
Mumbai: Thyrocare Technologies on Monday announced the sale of its entire shareholding in wholly owned subsidiary Nueclear Healthcare Limited (NHL) for approximately ₹141.40 crore. The board also approved the acquisition of immovable properties from NHL for an aggregate consideration of ₹20.58 crore. NHL Divestment Details The sale involves 1,11,11,000 equity shares of NHL, representing 100% of…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
